Catalyst Capital Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,936
Closed -$1.03M 445
2024
Q4
$1.03M Sell
1,936
-73
-4% -$41.2K 0.02% 150
2024
Q3
$1.21M Sell
2,009
-4
-0.2% -$2.27K 0.03% 132
2024
Q2
$1.09M Hold
2,013
0.03% 142
2024
Q1
$1.29M Buy
2,013
+58
+3% +$35.2K 0.03% 135
2023
Q4
$1.14M Sell
1,955
-10
-0.5% -$5.6K 0.03% 138
2023
Q3
$1.02M Sell
1,965
-281
-13% -$146K 0.03% 145
2023
Q2
$1.22M Buy
+2,246
New +$1.23M 0.04% 148
2022
Q3
Sell
-4,402
Closed -$2.07M 336
2022
Q2
$2.07M Sell
4,402
-79
-2% -$38.5K 0.09% 114
2022
Q1
$2.27M Hold
4,481
0.1% 120
2021
Q4
$2.37M Hold
4,481
0.11% 125
2021
Q3
$2.08M Buy
+4,481
New +$2.11M 0.1% 139
2021
Q2
Sell
-380
Closed -$175K 386
2021
Q1
$175K Hold
380
0.01% 249
2020
Q4
$202K Hold
380
0.01% 232
2020
Q3
$183K Sell
380
-70
-16% -$34.3K 0.01% 240
2020
Q2
$203K Buy
+450
New +$201K 0.01% 229
2016
Q2
Sell
-2,600
Closed -$352K 436
2016
Q1
$352K Buy
+2,600
New +$351K 0.06% 232
2015
Q2
Sell
-4,000
Closed -$478K 477
2015
Q1
$478K Buy
+4,000
New +$444K 0.05% 210
2014
Q2
Sell
-6,491
Closed -$581K 361
2014
Q1
$581K Buy
+6,491
New +$529K 0.13% 195

Other funds holding CHE

Catalyst Capital Advisors's CHE Position: Q1 2025 in Review

Catalyst Capital Advisors sold out of Chemed (CHE) in Q1 2025, closing a stake of 1,936 shares — an estimated $1.03M sold.

Catalyst Capital Advisors first reported a position in CHE in Q1 2014 and held it in 18 quarters. The position peaked at $2.37M in Q4 2021. 554 funds tracked by Wall St. Rank hold CHE as of Q1 2025.

  • Catalyst Capital Advisors reported no remaining Chemed position as of Q1 2025 after selling out during the quarter.
  • Catalyst Capital Advisors sold 1,936 Chemed shares in Q1 2025, an estimated $1.03M.
  • Catalyst Capital Advisors first reported a position in Chemed in Q1 2014 and held it in 18 quarters.
  • Catalyst Capital Advisors's Chemed position peaked at $2.37M in Q4 2021.
  • 554 funds tracked by Wall St. Rank held Chemed as of Q1 2025.

Based on Catalyst Capital Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.